ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag heart attack ecology disease medicine

PCSK9 Drug Reduces Heart Disease Risk
Diana Kwon | Mar 21, 2017 | 2 min read
A cholesterol-lowering drug significantly cut the risk of heart attack and stroke in a recent study. But is it worth the steep cost?
Notebook
The Scientist Staff | Feb 14, 1999 | 5 min read
Editor's Note: The news items on this page all originated from the American Association for the Advancement of Science annual meeting in Anaheim, Calif., Jan. 21-26. PLAQUE ATTACK A host of studies have bitten off the task of linking periodontitis with coronary heart disease. But without more evidence, scientists may find any cause-and-effect relationship between tooth disease and heart attacks hard to swallow, admitted James D. Beck, professor of dental ecology, at the University of North Caro
Alternative Medicines
The Scientist | Jul 1, 2012 | 10+ min read
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
microbiome
Do Commensal Microbes Stoke the Fire of Autoimmunity?
Amanda B. Keener | Jun 1, 2019 | 10+ min read
Molecules produced by resident bacteria and their hosts may signal immune cells to attack the body’s own tissues.
Novartis’s $9.7 Billion Purchase Includes Novel PCSK9 Inhibitor
Emily Makowski | Nov 25, 2019 | 2 min read
The pharmaceutical firm is buying The Medicines Company, which recently devoted its efforts into developing the cholesterol-lowering medication.
Book Excerpt from The Serengeti Rules
Sean B. Carroll | Mar 31, 2016 | 5 min read
In the introduction to the book, author Sean B. Carroll draws the parallels between ecological and physiological maladies.
Histology of mouse lungs using purple and green staining on a white background. Left: a healthy lung. Right: a fibrotic lung.<br><br>
Immunotherapy Treats Fibrosis in Mice
Alejandra Manjarrez, PhD | Sep 15, 2022 | 4 min read
Researchers report that vaccination against proteins found on profibrotic cells reduced liver and lung fibrosis in laboratory rodents.
Eat Yourself to Live: Autophagy’s Role in Health and Disease
Vikramjit Lahiri and Daniel J. Klionsky | Mar 1, 2018 | 10+ min read
New details of the molecular process by which our cells consume themselves point to therapeutic potential.
New MRIs on the Horizon
A. J. S. Rayl | Mar 19, 2000 | 7 min read
Courtesy of National Heart, Lung, and Blood InstituteMRI scans of the heart: upper left, torso with heart; upper right, cross section at aortic valve; lower left, lateral view of heart, pulmonic valve, and descending aorta; lower right, four-chamber view In the not too distant future, emergency rooms may well take on the aura of Star Trek's hospital bay. New, state-of-the-art magnetic resonance imaging (MRI) machines offer fast, efficient, and highly detailed data, allowing physicians to make im
The Proteasome: A Powerful Target for Manipulating Protein Levels
John Hines and Craig M. Crews | May 1, 2017 | 10+ min read
The proteasome’s ability to target and degrade specific proteins is proving useful to researchers studying protein function or developing treatments for diseases.

Run a Search

ADVERTISEMENT